Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics

VBLT POWR Grades

• VBLT scores best on the Sentiment dimension, with a Sentiment rank ahead of 71.14% of US stocks.
• The strongest trend for VBLT is in Momentum, which has been heading down over the past 47 weeks.
• VBLT ranks lowest in Momentum; there it ranks in the 4th percentile.

VBLT Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for VBLT is 0.01 -- better than just 7.14% of US stocks.
• Of note is the ratio of Vascular Biogenics Ltd's sales and general administrative expense to its total operating expenses; only 10.58% of US stocks have a lower such ratio.
• With a price/sales ratio of 190.4, Vascular Biogenics Ltd has a higher such ratio than 97.88% of stocks in our set.
• Stocks that are quantitatively similar to VBLT, based on their financial statements, market capitalization, and price volatility, are CBIO, AYLA, XCUR, PIRS, and ACIU.
• VBLT's SEC filings can be seen here. And to visit Vascular Biogenics Ltd's official web site, go to www.vblrx.com.

VBLT Valuation Summary

• VBLT's price/sales ratio is 186.4; this is 1542.29% higher than that of the median Healthcare stock.
• VBLT's price/sales ratio has moved NA NA over the prior 84 months.
• VBLT's EV/EBIT ratio has moved up 3.9 over the prior 84 months.

Below are key valuation metrics over time for VBLT.

VBLT Growth Metrics

• The 5 year cash and equivalents growth rate now stands at 8.11%.
• Its 4 year price growth rate is now at -63.75%.
• Its 2 year revenue growth rate is now at -94.95%.

VBLT's revenue has moved down $13,537,000 over the prior 33 months.

The table below shows VBLT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	0.771	-22.289	-27.345
2021-03-31	0.741	-23.552	-25.155
2020-12-31	0.922	-23.378	-24.225
2020-09-30	0.843	-19.831	-22.697
2020-06-30	0.729	-19.999	-21.776
2020-03-31	0.709	-15.585	-20.628

VBLT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VBLT has a Quality Grade of C, ranking ahead of 41.64% of graded US stocks.
• VBLT's asset turnover comes in at 0.015 -- ranking 378th of 677 Pharmaceutical Products stocks.
• ISEE, SRNE, and CNCE are the stocks whose asset turnover ratios are most correlated with VBLT.

The table below shows VBLT's key quality metrics over time.